PlutoSemi Glass Wafer Solutions Support Advanced Medical and IVD Applications

With the medical biotechnology and in vitro diagnostics (IVD) industries rapidly evolving toward higher precision, miniaturization, and high-throughput capabilities, the performance boundaries of key materials directly determine the upper limits of technological breakthroughs.

As a professional semiconductor material supplier, Plutosemi Co., Ltd. (International brand: PlutoSemi) relies on its independently controlled precision glass wafer processing system to provide integrated solutions from material selection to customized processing for application scenarios including microfluidic biochips, gene sequencing, and implantable medical devices.

Low-Fluorescence Glass Wafers Improve Detection Accuracy in Medical Testing

In the optical observation of microfluidic biochips and the solid-state carrier applications of gene sequencing, substrate fluorescence background noise and optical transmittance directly affect the purity and sensitivity of detection signals.

PlutoSemi’s low-fluorescence borosilicate glass wafers and quartz glass wafers are specifically designed to address these challenges. They provide excellent optical transparency across a wide spectral range and extremely low autofluorescence characteristics, effectively reducing detection background interference and significantly improving signal-to-noise ratio.

Leveraging these material advantages, PlutoSemi’s glass wafer products have been deeply integrated into high-end fields such as gene sequencing and medical biotechnology, and have attracted Australian customers to visit the company to discuss cooperation in medical testing chip processing.

High-Precision Glass Wafer Processing Supports Wafer-Level Medical Chip Manufacturing

Whether for microfluidic chip channel bonding or surface biochemical modification of gene sequencing chips, the surface flatness and thickness uniformity of glass wafers are critical factors determining process feasibility and product yield.

PlutoSemi has established a complete independent production line covering grinding, CMP polishing, and precision inspection.

Its ultra-high-flatness borosilicate glass wafers achieve nanometer-level surface roughness and micrometer-level thickness tolerance through strictly controlled chemical mechanical polishing processes.

The company has established Class 1,000 and Class 100 cleanrooms to fundamentally prevent cross-contamination.

This capability makes PlutoSemi one of the few manufacturers in South China capable of simultaneously completing fully customized Silicon Wafer and glass wafer processes, providing reliable flatness assurance for wafer-level manufacturing and mass production of in vitro diagnostic chips.

Bio-Inert Glass Wafers Enable Reliable Implantable Medical Devices

Implantable medical devices place extremely strict requirements on packaging materials, including biocompatibility, chemical inertness, and long-term hermetic sealing performance.

The bio-inert polished glass wafers developed by PlutoSemi, with excellent chemical stability and dense surface structures, can serve as sealing cover glass for implantable medical devices.

They effectively prevent body fluid corrosion and gas penetration, ensuring long-term reliable operation of devices in internal biological environments.

The company’s products have passed ISO9001:2015 Quality Management System certification, ISO14001:2015 Environmental Management System certification, ISO45001:2018 Occupational Health and Safety Management System certification, as well as international certifications including RoHS and REACH.

The company has also accumulated more than 20 patented technologies related to glass wafer substrate manufacturing and processing.

In terms of precision processing, PlutoSemi supports comprehensive non-standard customization services including size, thickness, surface roughness, polishing grade, slotting, drilling, edge chamfering, and coating pre-treatment, flexibly adapting to different implantable device packaging design requirements.

Full-Process Customization Capabilities Support Global Medical Innovation

The reason PlutoSemi continues to gain recognition from leading enterprises and research institutions in the medical biotechnology and in vitro diagnostics fields lies not only in its broad material portfolio, but also in its full-chain service capabilities from R&D to mass production.

The company has established a one-to-one customized service system covering the entire process from “drawing confirmation → process sampling → parameter adjustment → sample retesting → mass production.”

This system supports both extremely small-batch R&D samples and stable mass production supply.

Currently, PlutoSemi’s glass wafer production capacity has reached an equivalent of 50,000 6-inch wafers per month.

Its products are exported to Germany, Australia, Japan, South Korea, the United States, and other global markets.

Recently, PlutoSemi reached a long-term annual procurement agreement for hundreds of thousands of silicon wafers and glass wafers with a well-known German company. All product specifications passed European Union standards certification, marking a key transition for domestic glass wafers from “local substitution” toward “global supply” in the high-end semiconductor materials market.

Advancing Medical Biotechnology and IVD Innovation Through Glass Wafer Technology

In the future, PlutoSemi will continue to focus on precision glass wafer processing technology, providing higher-quality and more consistent glass wafer products to empower innovation and breakthroughs in the medical biotechnology and in vitro diagnostics industries.